Nonprofit · EIN 93-0571472
NATIONAL PSORIASIS FOUNDATION
Tax-exempt · ALEXANDRIA, VA 22314
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $12,648,481 | $11,737,962 | $910,519 | $14,911,131 | $4,949,799 | $9,961,332 |
| June 30, 2024 | 990 | $11,595,768 | $12,586,852 | -$991,084 | $14,679,906 | $5,940,214 | $8,739,692 |
| June 30, 2023 | 990 (amended) | $11,591,439 | $13,763,392 | -$2,171,953 | $13,817,026 | $4,798,376 | $9,018,650 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $10,587,360
- of which government grants
- $399,409
- Membership dues
- $23,777
- Program service revenue
- $2,021,113
- Investment income
- $721,070
- Net gain from sales of assets
- $418,229
- Net income from fundraising events
- -$681,062
- Other revenue
- -$681,062
Expenses
- Grants and similar amounts paid
- $2,513,494
- Compensation of officers, directors and key employees
- $1,192,804
- Other salaries and wages
- $4,004,877
- Salaries, compensation and benefits (total)
- $6,109,248
- Professional fundraising fees
- $0
- Legal fees
- $40,750
- Accounting fees
- $27,500
- Occupancy
- $119,168
- Travel
- $293,315
- Depreciation
- $57,286
- Program services (functional)
- $9,233,439
- Management and general (functional)
- $1,295,695
- Fundraising (functional)
- $1,208,828
Balance sheet and other
- Total assets, start of year
- $14,679,906
- Total assets, end of year
- $14,911,131
- Total liabilities, end of year
- $4,949,799
- Net assets, end of year
- $9,961,332
- Land, buildings and equipment
- $118,464
- Publicly traded securities
- $9,324,619
- Net assets without donor restrictions
- $6,032,984
- Net assets with donor restrictions
- $3,928,348
- Gross unrelated business income
- $1,007,127
- Gross receipts
- $14,318,314
- Employees
- 57
- Volunteers
- 624
- Year formed
- 1968
- State of legal domicile
- VA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| LEAH MCCORMICK HOWARD | PRESIDENT/CEO Officer | 40 | $399,224 | $43,603 |
| GUY EAKIN | CHIEF SCIENTIFC & MEDICAL OFFICER Key employee | 40 | $254,350 | $33,812 |
| JENNIFER FAGERSTROM | CHIEF REVENUE OFFICER Key employee | 40 | $231,654 | $47,071 |
| RONALD GOLDSMAN | CHIEF FINANCIAL OFFICER Officer | 40 | $226,395 | $20,625 |
| JENNIFER O'CONNOR | VICE PRESIDENT OF ADVANCEMENT Highest-paid employee | 40 | $160,412 | $22,921 |
| JASON HARRIS | VICE PRESIDENT OF GOVERNMENT RELATIONS & ADVOCACY Highest-paid employee | 40 | $158,156 | $18,207 |
| BREANNA BAER | VICE PRESIDENT, FIELD DEVELOPMENT & OPERATIONS Highest-paid employee | 40 | $149,303 | $24,983 |
| KATHERINE SOUTHWICK | VICE PRESIDENT OF MARKETING & COMMUNICATIONS Highest-paid employee | 40 | $144,256 | $17,388 |
| CAROL OSTROW | CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| EYAL OFIR | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| MARY CARROLL | SECRETARY Trustee or director, Officer | 1 | $0 | $0 |
| BRIAN JANSSEN | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| ANDY BLAUVELT MD | MEDICAL BOARD CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| RON GRAU | PAST CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| KEN ANSIN | DIRECTOR Trustee or director | 1 | $0 | $0 |
12 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| KELLI AMERINE | DIRECTOR Trustee or director | 1 | $0 |
| DIANA SANDLER MD | DIRECTOR Trustee or director | 1 | $0 |
| CHRISTINE LINDSAY | DIRECTOR Trustee or director | 1 | $0 |
| LARRY GREEN MD | DIRECTOR Trustee or director | 1 | $0 |
| MICHAEL GRAFF | DIRECTOR Trustee or director | 1 | $0 |
| ELAINE HUSNI MD | DIRECTOR Trustee or director | 1 | $0 |
| VALERIE HARRISON | DIRECTOR Trustee or director | 1 | $0 |
| KATHLEEN GALLANT | DIRECTOR Trustee or director | 1 | $0 |
| JONATHAN SCOTT | DIRECTOR Trustee or director | 1 | $0 |
| NICOLE KUBIN FROM MAY 2025 | DIRECTOR Trustee or director | 1 | $0 |
| LEON KIRCIK MD FROM MAY 2025 | DIRECTOR Trustee or director | 1 | $0 |
| KEITH GRAFF FROM MAY 2025 | DIRECTOR Trustee or director | 1 | $0 |
990 for the year ended June 30, 2024: 28 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| LEAH MCCORMICK HOWARD | PRESIDENT/CEO Officer | 40 | $304,524 | $35,435 |
| JENNIFER FAGERSTROM | CHIEF REVENUE OFFICER Key employee | 40 | $227,737 | $39,539 |
| RONALD GOLDSMAN | CHIEF FINANCIAL OFFICER Officer | 40 | $214,283 | $18,621 |
| JASON HARRIS | VICE PRESIDENT OF GOVERNMENT RELATIONS & ADVOCACY Highest-paid employee | 40 | $153,312 | $18,346 |
| RENE ISLAS | CHIEF OF STAFF Highest-paid employee | 40 | $140,595 | $26,666 |
| GUY EAKIN | CHIEF SCIENTIFIC & MEDICAL OFFICER Key employee | 40 | $153,257 | $12,559 |
| BREANNA BAER | VICE PRESIDENT, FIELD DEVELOPMENT & OPERATIONS Highest-paid employee | 40 | $141,302 | $22,187 |
| KATHERINE SOUTHWICK | VICE PRESIDENT OF MARKETING & COMMUNICATIONS Highest-paid employee | 40 | $136,394 | $16,100 |
| ROBERT FRIESEL | DIRECTOR OF RESEARCH & MEDICAL AFFAIRS Highest-paid employee | 40 | $125,719 | $20,882 |
| RANDY BERANEK THRU DEC 2021 | FORMER PRESIDENT/CEO Former | 40 | $53,802 | $0 |
| CAROL OSTROW | CHAIR-ELECT Trustee or director, Officer | 1 | $0 | $0 |
| EYAL OFIR | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| MIKE REFERMAT | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| RICHARD SEIDEN | SECRETARY Trustee or director, Officer | 1 | $0 | $0 |
| RON GRAU | PAST CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| JONATHAN SCOTT | DIRECTOR Trustee or director | 1 | $0 | $0 |
| LARRY GREEN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARY CARROLL | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MICHAEL GRAFF | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARK OBERMAN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JASON LICHTEN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PETE MILLER THRU MARCH 2023 | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MATTHEW T KISELICA | DIRECTOR Trustee or director | 1 | $0 | $0 |
| APRIL ARMSTRONG MD THRU JUNE 2023 | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ELAINE HUSNI MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| VALERIE HARRISON FROM JUNE 2023 | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DIANA SANDLER FROM JUNE 2023 | DIRECTOR Trustee or director | 1 | $0 | $0 |
| BRIAN JANSSEN FROM JUNE 2023 | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended June 30, 2023: 23 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| RANDY BERANEK OFFICER THRU DEC 2021 | FORMER PRESIDENT/CEO Former | 40 | $303,058 | $9,214 |
| LEAH MCCORMICK HOWARD | PRESIDENT/CEO Officer | 40 | $291,746 | $15,601 |
| JENNIFER FAGERSTROM | CHIEF REVENUE OFFICER Key employee | 40 | $237,132 | $25,293 |
| MICHAEL MACLOED | DIRECTOR OF PRINCIPAL GIVING Highest-paid employee | 40 | $141,110 | $19,103 |
| KRISTINE BOCKMIER | VP OF FIELD DEVELOPMENT & OPERATIONS Highest-paid employee | 40 | $146,058 | $9,627 |
| ANDREA CLAY | VP OF CORPORATE PARTNERSHIPS Highest-paid employee | 40 | $146,606 | $8,429 |
| RONALD GOLDSMAN | CHIEF FINANCIAL OFFICER Officer | 40 | $142,053 | $3,477 |
| RON GRAU | CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| CAROL OSTROW | CHAIR-ELECT Trustee or director, Officer | 1 | $0 | $0 |
| EYAL OFIR | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| MIKE REFERMAT | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| RICHARD SEIDEN | SECRETARY Trustee or director, Officer | 1 | $0 | $0 |
| RAYMOND CHIP NEWTON | PAST CHAIR Trustee or director | 1 | $0 | $0 |
| JONATHAN SCOTT | DIRECTOR Trustee or director | 1 | $0 | $0 |
| LARRY GREEN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARY CARROLL | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MICHAEL GRAFF | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARK OBERMAN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JASON LICHTEN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PETE MILLER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MATTHEW T KISELICA | DIRECTOR Trustee or director | 1 | $0 | $0 |
| APRIL ARMSTRONG MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ELAINE HUSNI MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1800 DIAGONAL RD STE 360, ALEXANDRIA, VA 22314-2842
- Principal officer (990 for 2024)
- LEAH MCCORMICK HOWARD, 1800 DIAGONAL ROAD 360, ALEXANDRIA, VA 22314
- Signed the 990
- RONALD GOLDSMAN, CHIEF FINANCIAL OFFICER
- Phone
- (503) 244-7404
- Website
- WWW.PSORIASIS.ORG
- Return prepared by
- MCDONALD JACOBS PC
Mission
THE NATIONAL PSORIASIS FOUNDATION PROVIDES PEOPLE WITH PSORIASIS AND PSORIATIC ARTHRITIS THE SERVICES THEY NEED TO BEST MANAGE THEIR CONDITION, WHILE PROMOTING RESEARCH TO FIND A CURE.
Program accomplishments
- RESEARCHTHE NATIONAL PSORIASIS FOUNDATION (NPF) CONTINUES TO BE A LEADER IN FUNDING AND DRIVING RESEARCH TO CURE PSORIATIC DISEASE. IN FY 2025, NPF INVESTED OVER $2.5M IN RESEARCH GRANTS AND FELLOWSHIP AWARDS TOWARDS OUTSIDE-THE-BOX IDEAS AND SUPPORTED YOUNG RESEARCHERS, ENSURING PROGRESS TOWARD NOVEL TREATMENTS. THROUGH PARTNERSHIPS SUCH AS THE ACCELERATED MEDICINES PARTNERSHIP FOR AUTOIMMUNE AND IMMUNE-MEDIATED DISEASES (AMP AIM), NPF HAS WORKED WITH INDUSTRY AND NONPROFIT STAKEHOLDERS TO IDENTIFY MOLECULAR PATHWAYS AND ACCELERATE TREATMENT DEVELOPMENT. BRIDGE GRANTS HAVE ENABLED NEAR-MISS NIH RESEARCH APPLICATIONS TO SECURE ADDITIONAL DATA AND EVENTUALLY OBTAIN FEDERAL FUNDING, MULTIPLYING DONOR INVESTMENT MANY TIMES OVER. OVER THE LIFETIME OF THIS GRANT OFFERING, EVERY BRIDGE GRANT RECIPIENT SUCCESSFULLY OBTAINED FURTHER FUNDING AFTER RESUBMISSION, TURNING $1.5 MILLION IN NPF GRANTS INTO $13.5 MILLION IN FEDERAL SUPPORT. NPF COLLABORATED WITH THE GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES AND COMMUNITY ORGANIZATIONS TO EXPAND ACCESS TO DERMATOLOGIC CARE IN UNDERSERVED WASHINGTON, D.C. NEIGHBORHOODS. QUALITATIVE RESEARCH, SUCH AS THE S.T.R.A.N.D. INITIATIVE, EDUCATED HAIR STYLISTS ON RECOGNIZING SCALP CONDITIONS, BROADENING COMMUNITY AWARENESS AND EARLY DETECTION. THE NPF HEALTH CARE PROVIDER DIRECTORY WAS ENHANCED IN 2025 BY REQUIRING PROVIDERS TO ATTEST TO DELIVERING GUIDELINE-BASED, HIGH-QUALITY CARE FOCUSED ON MINIMAL DISEASE ACTIVITY AND CONTINUOUS PROFESSIONAL GROWTH.Expenses $3,442,648 · grants $2,513,494
- PROFESSIONAL EDUCATIONNPF CONTINUED TO EXPAND AND STRENGTHEN MEDICAL EDUCATION PROGRAMMING TARGETING HEALTH CARE PROVIDERS AT ALL LEVELS AND STAGES OF CAREER. THE 26TH ANNUAL RESIDENTS AND RHEUMATOLOGY FELLOWS MEETING OFFERED DERMATOLOGY RESIDENTS AND RHEUMATOLOGY FELLOWS THE LATEST IN PSORIATIC DISEASE TREATMENT PRESENTED BY EXPERTS IN THE FIELD. THROUGH ITS DEDICATION TO EDUCATING HEALTH CARE PROVIDERS ON PSORIATIC DISEASE AND ITS RELATED DISEASES, NPF HAS EARNED ACCREDITATION AS A PROVIDER OF CONTINUING MEDICAL EDUCATION. IT'S PART OF OUR EFFORTS TO ENSURE ALL DIFFERENT TYPES OF HEALTH CARE PROVIDERS UNDERSTAND THIS COMPLICATED DISEASE. NPF OFFERS THE PSOUND BYTES CONTINUING MEDICAL EDUCATION PODCASTS, WEBINARS, AND IN-PERSON CLASSES AND SEMINARS FOR A WIDE RANGE OF AUDIENCES. IN FY 2025, THE NPF CELEBRATED THE INDEXING OF THE JOURNAL OF PSORIASIS AND PSORIATIC ARTHRITIS, A PEER REVIEWED OUTLET FEATURING CME ARTICLES, ALLOWING MANY MORE RESEARCHERS, CLINICIANS, AND PATIENTS TO ACCESS VALUABLE INFORMATION IN EACH ARTICLE.Expenses $1,318,997 · revenue $12,000
- ADVOCACYNPF FURTHER AMPLIFIED ITS ADVOCACY EFFORTS. THE ORGANIZATION CONTINUES TO CHAMPION PATIENT-FRIENDLY LEGISLATION, NOTABLY THE SAFE STEP ACT, AND HAS SUPPORTED STEP THERAPY REFORMS AND COPAY ACCUMULATOR PROTECTIONS ACROSS 40 STATES. NPF REGULARLY ADVOCATES ON CAPITOL HILL FOR BETTER CARE, ACCESS, AND FAIR PRICING. IN FY 2025, NPF PROACTIVELY EDUCATED ITS COMMUNITY ABOUT SIGNIFICANT MEDICARE CHANGES THROUGH ARTICLES, PODCASTS, AND WEBINARS, HELPING PATIENTS NAVIGATE NEW OUT-OF-POCKET MAXIMUMS AND PRESCRIPTION OPTIONS.Expenses $1,211,482
- EDUCATION, OUTREACH, AND PATIENT SERVICESNPF'S PUBLIC RELATIONS AND EDUCATION CAMPAIGNS REACHED BROAD AUDIENCES, FEATURING DYNAMIC CONTENT TO REDUCE STIGMA AND DRIVE AWARENESS. THE #THISISPSORIASIS CAMPAIGN UTILIZED MEDIA TOURS AND VIDEOS FROM COMMUNITY MEMBERS TO DEBUNK MYTHS AND FOSTER UNDERSTANDING. NPF ALSO LAUNCHED IMPACTFUL CAMPAIGNS FOR RARE FORMS OF THE DISEASE, SUCH AS GENERALIZED PUSTULAR PSORIASIS (GPP), EDUCATING PATIENTS AND PROVIDERS TO SAVE LIVES THROUGH TIMELY DIAGNOSIS AND INTERVENTION. NPF OPTIMIZED ITS DIGITAL PRESENCE, MAKING PSORIASIS.ORG A TRUSTED RESOURCE FOR OVER 4 MILLION ANNUAL VISITORS. EFFORTS INCLUDED THE LAUNCH OF THE RESOURCE LIBRARY AND THE MONTHLY PSORIASIS INSIDER NEWSLETTER, SIGNIFICANTLY INCREASING ACCESS TO RELIABLE INFORMATION FOR BOTH PATIENTS AND PROVIDERS. SINCE 2016, NPF'S PATIENT NAVIGATION CENTER HAS SUPPORTED OVER 90,000 PATIENTS AND THEIR CAREGIVERS WITH FREE, PERSONALIZED SUPPORT DESIGNED TO HELP THEM UNDERSTAND PSORIATIC DISEASE AND TREATMENT OPTIONS, NAVIGATE INSURANCE CHALLENGES, AND FIND THE APPROPRIATE HEALTH CARE PROVIDER.Expenses $3,260,312 · revenue $1,001,986
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 93-0571472
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1968
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G46Z)
- Assets (IRS master file)
- $14,911,131
- Income (IRS master file)
- $14,318,314
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $12,648,481 | $11,737,962 | $14,911,131 | XML |
| 990-T | June 2025 | – | – | – | IRS |
| 990 | June 2024 | $11,595,768 | $12,586,852 | $14,679,906 | XML |
| 990-T | June 2024 | – | – | – | IRS |
| 990 | June 2023 | $11,591,439 | $13,763,392 | $13,817,026 | XML |
| 990-T | June 2023 | – | – | – | IRS |
| 990 | June 2022 | $13,390,353 | $12,538,110 | $13,977,875 | IRS |
| 990-T | June 2022 | – | – | – | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990-T | June 2021 | – | – | – | IRS |
| 990 | June 2019 | – | – | – | IRS |
| 990 | June 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 93-0571472).
Questions about NATIONAL PSORIASIS FOUNDATION
- What is the EIN of NATIONAL PSORIASIS FOUNDATION?
- The employer identification number (EIN) of NATIONAL PSORIASIS FOUNDATION is 93-0571472.
- Is NATIONAL PSORIASIS FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1968.
- Are donations to NATIONAL PSORIASIS FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does NATIONAL PSORIASIS FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of NATIONAL PSORIASIS FOUNDATION due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did NATIONAL PSORIASIS FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of NATIONAL PSORIASIS FOUNDATION?
- The 990 for the year ended June 30, 2025 names LEAH MCCORMICK HOWARD.
- Who are the officers and directors of NATIONAL PSORIASIS FOUNDATION?
- The 990 for the year ended June 30, 2025 lists 27 people; 8 received compensation from the organization, the highest $399,224 (LEAH MCCORMICK HOWARD, PRESIDENT/CEO).
- How much revenue does NATIONAL PSORIASIS FOUNDATION have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $12,648,481, expenses of $11,737,962 and total assets of $14,911,131 at year end.
Other nonprofits in ALEXANDRIA
- AMERICAN SOCIETY OF CLINICAL ONCOLOGY EIN 13-6180380 · last filed 990 for 2024
- PUBLIC HEALTH ACCREDITATION BOARD EIN 26-0333211 · last filed 990 for 2025
- AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES EIN 23-7373091 · last filed 990 for 2025
- AMER ACAD OF OTOLARNYGOLOGY HEAD & NECK SURGERY FOUNDATION INC EIN 52-1219434 · last filed 990 for 2025
- SOCIETY OF GENERAL INTERNAL MEDICINE EIN 23-2532466 · last filed 990 for 2025
- NATIONAL CERTIFICATION BOARD FOR ACUPUNCTURE AND HERBAL MEDICINE EIN 11-2760706 · last filed 990 for 2024
- AMERICAN COUNCIL OF THE BLIND INC EIN 58-0914436 · last filed 990 for 2025
- AEROSPACE MEDICAL ASSOCIATION EIN 30-0697646 · last filed 990 for 2025
All nonprofits in ALEXANDRIA · Virginia · Voluntary health associations and medical disciplines